DETERMINATION OF (-NICARDIPINE AND (-)-NICARDIPINE CONCENTRATIONS IN HUMAN SERUM AND THEIR CORRELATION WITH THE ANTIHYPERTENSIVE EFFECT AFTER ORAL-ADMINISTRATION OF RACEMIC NICARDIPINE())
T. Iwaoka et al., DETERMINATION OF (-NICARDIPINE AND (-)-NICARDIPINE CONCENTRATIONS IN HUMAN SERUM AND THEIR CORRELATION WITH THE ANTIHYPERTENSIVE EFFECT AFTER ORAL-ADMINISTRATION OF RACEMIC NICARDIPINE()), European Journal of Clinical Pharmacology, 48(5), 1995, pp. 345-349
Serum (+)- and (-)-nicardipine concentrations were determined after or
al administration of racemic nicardipine, and the relationship between
the concentration of each enantiomer and the percentage change in blo
od pressure was investigated, Serum concentrations of (+)-and (-)-nica
rdipine were assayed separately by a method combining high-performance
liquid chromatography (HPLC) with gas chromatography - mass spectrome
try (GS-MS). Linear relationships were found with serum concentrations
of 0.25-80 mg . ml(-1) for both enantiomers of nicardipine with corre
lation coefficients of greater than 0.999, A single oral dose of 40 mg
racemic nicardipine was given to 15 patients with essential hypertens
ion. Serum (+)-nicardipine concentration was 2-3 times higher than the
concentration of (-)-nicardipine 1, 2, and 3 after drug administratio
n, The logarithmically transformed value of the serum (+)-nicardipine
concentration was inversely correlated with the percentage change in s
ystolic blood pressure, the correlation being statistically significan
t 1 and 2 h after drug administration, and also inversely correlated w
ith the percentage change in diastolic blood pressure 1, 2 and 3 h aft
er drug administration. However, the logarithmically transformed value
of serum (-)-nicardipine showed no significant correlations with the
percentage change in either systolic or diastolic blood pressure.